A small molecule inhibitor of Pim-1 kinase with activity in both hematological and solid tumor malignancies

Jeremy Lamb(SuperGen (United States)), David J. Bearss(Unknown), Steven L. Warner(SuperGen (United States)), Cory L. Grand(SuperGen (United States)), Hariprasad Vankayalapati(University of Utah), Eric Gourley(SuperGen (United States)), Xiaohui Liu(Hebei Medical University)

Molecular Cancer Therapeutics

November 1, 2007

Cited by 2

Related Papers

NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers

|Cancer Cell|2013|302

Paracrine Action of Mesenchymal Stem Cells Revealed by Single Cell Gene Profiling in Infarcted Murine Hearts

|PLoS ONE|2015|93

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

|PLoS ONE|2020|82

The mitotic serine threonine kinase, <i>Aurora-2</i>, is a potential target for drug development in human pancreatic cancer

|Molecular Cancer Therapeutics|2004|78

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel

|Clinical Cancer Research|2016|77